| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V87583 | (±)15-HEDE | 77159-57-0 | (±)15-HEDE is a racemic mixture of the monohydroxy fatty acids 15(R)-HEDE and 15(S)-HEDE. |
|
V102788 | 15(S)-HEDE | 92693-04-4 | 15(S)-HEDE (Compound 8) is an analog of 15-HEDE and inhibits 5-lipoxygenase with IC50 of 26 μM. |
|
V124961 | 3-(4-Hydroxy-3-methoxyphenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one | 104236-73-9 | 3-(4-Hydroxy-3-methoxyphenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one is a selective lipid peroxidation inhibitor. |
|
V73506 | 3-O-Acetyl-11-hydroxy-beta-boswellic acid (3α-O-acetyl-11α-hydroxy-beta-boswellic acid) | 146019-25-2 | 3-O-Acetyl-11-hydroxy-beta-boswellic acid is a 5-lipoxygenase (5-LO) inhibitor. |
|
V131453 | CGS 24891 | 134823-10-2 | CGS 24891 is an orally effective 5-lipoxygenase (5-LO) inhibitor with an IC50 value of 0.051 μM in guinea pigs and 0.11 μM in dogs. |
|
V138379 | KC-11404 | 148490-22-6 | KC-11404 is an orally effective antihistamine and 5-lipoxygenase inhibitor with an IC50 value of 0.9 μM against guinea pig 5-lipoxygenase. |
|
V3027 | ML355 | 1532593-30-8 | ML355 is the first selective, orally bioavailable 12-LOX inhibitor which displays high potency (IC50 of 0.34 μM) against 12-LOX and excellent selectivity over related lipoxygenases and cyclooxygenases. |
|
V144425 | Ruthenoleuton | Ruthenoleuton is a 5-lipoxygenase (5-LOX) inhibitor with an IC50 of 3.49 μM and a Ki of 0.80 μM. | |
|
V145198 | Speranskoside | 219917-70-1 | Speranskoside is a dual COX-2/15-LOX inhibitor with a COX-2 IC50 of 2.62 μg/mL and a 15-LOX IC50 of 5.51 μg/mL. |
|
V147154 | WY-50295 | 123016-21-7 | WY-50295 is an orally effective selective 5-lipoxygenase inhibitor. |
|
V29841 | β-Boswellic acid | 631-69-6 | β-Boswellic acid is extracted from the gum resin of Boswellia serrate. |
|
V10619 | AKBA (Acetyl-11-keto-β-boswellic acid) | 67416-61-9 | AKBA,an active triterpenoid isolated from Boswellia serrate,is an antiangiogenic and neuroprotective agent as well asa novel Nrf2 activator. |
|
V2108 | Zileuton (A 64077; Abbott 64077) | 111406-87-2 | Zileuton (also known as A-64077;Abbott 64077; ZYFLO; ZYFLO CR)is a novel, potent and orally bioactive inhibitor of 5-lipoxygenase, and thus inhibits leukotrienes (LTB4, LTC4, LTD4, and LTE4) formation, it was introduced in 1996 to decrease the symptoms of asthma. |